These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36138465)

  • 1. Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in critically ill patients requiring continuous renal replacement therapy: study protocol of the GO NEUTRAL randomized controlled trial.
    Bitker L; Pradat P; Dupuis C; Klouche K; Illinger J; Souweine B; Richard JC
    Trials; 2022 Sep; 23(1):798. PubMed ID: 36138465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Urine Output Using Advanced Hemodynamic Monitoring in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Bitker L; Biscarrat C; Yonis H; Chivot M; Chauvelot L; Chazot G; Mezidi M; Deniel G; Richard JC
    Blood Purif; 2024; 53(3):189-199. PubMed ID: 38104538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): a pilot clinical trial protocol.
    Murugan R; Chang CH; Raza M; Nikravangolsefid N; Huang DT; Palevsky PM; Kashani K;
    BMJ Open; 2023 Jul; 13(7):e075960. PubMed ID: 37419639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study.
    Murugan R; Kerti SJ; Chang CH; Gallagher M; Neto AS; Clermont G; Ronco C; Palevsky PM; Kellum JA; Bellomo R
    Blood Purif; 2022; 51(5):397-409. PubMed ID: 34289471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of hemodynamic instability associated with preload-dependence during continuous renal replacement therapy in a prospective observational cohort of critically ill patients.
    Chazot G; Bitker L; Mezidi M; Chebib N; Chabert P; Chauvelot L; Folliet L; David G; Provoost J; Yonis H; Richard JC
    Ann Intensive Care; 2021 Jun; 11(1):95. PubMed ID: 34125314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid Overload and Precision Net Ultrafiltration in Critically Ill Patients.
    Murugan R; Kazory A; Sgarabotto L; Ronco C
    Cardiorenal Med; 2023; 13(1):9-18. PubMed ID: 36202071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafiltration in critically ill patients treated with kidney replacement therapy.
    Murugan R; Bellomo R; Palevsky PM; Kellum JA
    Nat Rev Nephrol; 2021 Apr; 17(4):262-276. PubMed ID: 33177700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VolumE maNagement Under body composition monitoring in critically ill patientS on CRRT: study protocol for a randomized controlled trial (VENUS trial).
    Oh HJ; An JN; Oh S; Rhee H; Lee JP; Kim DK; Ryu DR; Kim S
    Trials; 2018 Dec; 19(1):681. PubMed ID: 30541593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion-based deresuscitation during continuous renal replacement therapy: A before-after pilot study (The early dry Cohort).
    Ruste M; Sghaier R; Chesnel D; Didier L; Fellahi JL; Jacquet-Lagrèze M
    J Crit Care; 2022 Dec; 72():154169. PubMed ID: 36201978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced fluid removal versus usual care in intensive care patients with high-risk acute kidney injury and severe fluid overload (FFAKI): study protocol for a randomised controlled pilot trial.
    Berthelsen RE; Itenov T; Perner A; Jensen JU; Ibsen M; Jensen AEK; Bestle M
    Trials; 2017 Apr; 18(1):189. PubMed ID: 28438182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of U.S. Critical Care Practitioners on Net Ultrafiltration Prescription and Practice among Critically Ill Patients Receiving Kidney Replacement Therapy.
    Chen H; Murugan R
    J Crit Care Med (Targu Mures); 2021 Oct; 7(4):272-282. PubMed ID: 34934817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid Management during Continuous Renal Replacement Therapy: A Case-Based Approach.
    Neyra JA; Mehta RL; Murugan R
    Nephron; 2023; 147(12):782-787. PubMed ID: 37793364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Net Ultrafiltration during Continuous Renal Replacement Therapy: Impact of Admission Diagnosis and Association with Mortality.
    Sansom B; Udy A; Presneill J; Bellomo R
    Blood Purif; 2024; 53(3):170-180. PubMed ID: 37992695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial.
    Pereira RA; Virella D; Perdigoto R; Marcelino P; Saliba F; Germano N
    Trials; 2023 Aug; 24(1):534. PubMed ID: 37582719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.